D
Inhibikase Therapeutics, Inc. IKT
$2.37 $0.010.42%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Total Cash And Short-Term Investments -59.15% -18.56% -26.43% -21.27% -19.60%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -22.81% -59.87% 15.67% 106.12% -33.22%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 108.42% 42.56% -5.07% -34.30% -17.24%
Total Current Assets -51.29% -20.40% -23.95% -19.03% -20.17%

Total Current Assets -51.29% -20.40% -23.95% -19.03% -20.17%
Net Property, Plant & Equipment -16.61% -13.95% -11.94% -10.42% -9.24%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets -50.41% -20.25% -23.70% -18.87% -19.99%

Total Accounts Payable 88.68% 3.61% 100.03% -11.95% -2.59%
Total Accrued Expenses 6.24% -18.87% 10.96% 21.62% 1.49%
Short-term Debt -59.56% -36.81% -26.51% -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -4.60% 0.66% 0.73% 0.74% 0.68%
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities 32.47% -12.49% 23.11% 25.41% 0.32%

Total Current Liabilities 32.47% -12.49% 23.11% 25.41% 0.32%
Long-Term Debt -- -- -- -- --
Short-term Debt -59.56% -36.81% -26.51% -- --
Capital Leases -- -56.09% -35.29% -25.54% -19.33%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 31.56% -13.08% 21.61% 23.26% -0.70%

Common Stock & APIC 0.18% 4.19% 0.58% 0.18% 0.19%
Retained Earnings -7.55% -6.93% -6.95% -6.66% -7.91%
Treasury Stock & Other 280.00% 44.44% -300.00% 1,000.00% 94.12%
Total Common Equity -110.41% -24.79% -38.27% -26.90% -22.84%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -110.41% -24.79% -38.27% -26.90% -22.84%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -110.41% -24.79% -38.27% -26.90% -22.84%

Weiss Ratings